N22305
yw33b02.s1 Morton Fetal Cochlea Homo sapiens cDNA clone IMAGE:253995 3' similar to gb:X69181 60S RIBOSOMAL PROTEIN L31 (HUMAN), mRNA sequence.
421
mRNA
Homo sapiens
DJ952666
JP 2010500568-A/39347: ORGAN-SPECIFIC PROTEINS AND METHODS OF THEIR USE.
194
PRT
Homo sapiens
OG658691
JP 2021500321-A/22305: METHODS AND COMPOSITIONS FOR INHIBITING ADAM10 BIOLOGICAL ACTIVITIES.
189
PRT
synthetic construct
MD754547
JP 2019507579-A/22305: MATERIALS AND METHODS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY.
20
DNA
synthetic construct
DM758999
JP 2014079248-A/22305: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
PD710219
JP 2021530475-A/22301: De novo Design of Protein Switches.
59
PRT
synthetic construct
DJ151685
JP 2007228956-A/22303: Method for identification of useful proteins derived from brewery yeast.
25
DNA
Saccharomyces pastorianus
MD268438
JP 2020517247-A/22305: A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof.
20
DNA
synthetic construct
LV568127
JP 2017029159-A/22305: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
PA337953
JP 2021522188-A/22305: Compositions and Methods for Multiplexed Tumor Vaccination with Endogenous Gene Activation.
20
DNA
synthetic construct
HV878846
JP 2010507387-A/22257: Novel siRNAs and Methods of Use Thereof.
21
RNA
synthetic construct
MC164149
JP 2019500349-A/22305: COMPOSITIONS AND METHODS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES.
18
RNA
synthetic construct
DM796763
JP 2014068652-A/22305: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
PA393028
JP 2021533803-A/22111: FASL IMMUNOMODULATORY GENE THERAPY COMPOSITIONS AND METHODS FOR USE.
26
DNA
Homo sapiens
MC550805
JP 2019525738-A/22305: BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES.
121
PRT
synthetic construct
MB811563
JP 2019502674-A/22305: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
37
PRT
synthetic construct
DL904049
JP 2014205669-A/22305: Method of constructing and screening libraries of peptide structures.
25
PRT
synthetic construct
OG506491
JP 2018534252-A/22305: PHARMACEUTICAL ASSOCIATION FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF.
30
PRT
synthetic construct
LX119921
JP 2017506877-A/22303: Analysis of Nucleic Acids Associated With Single Cells Using Nucleic Acid Barcodes.
16
DNA
synthetic construct
HZ527086
JP 2016501039-A/22305: COMPOSITIONS AND METHODS FOR CREATING ALTERED AND IMPROVED CELLS AND ORGANISMS.
40
DNA
synthetic construct
DL031319
JP 2005512499-A/22305: Diagnosis of existing illnesses or that praedisposition for determined illnesses.
664
DNA
synthetic construct
PA526789
JP 2022502046-A/9571: ADENO-ASSOCIATED VIRUS COMPOSITIONS FOR TARGETED GENE THERAPY.
21
DNA
synthetic construct
DD802575
JP 2008525033-A/22305: Group B Streptococcus.
284
PRT
Streptococcus agalactiae
OG751824
JP 2021120380-A/22305: CANCER NEOEPITOPES.
9
PRT
Homo sapiens
HW857529
JP 2015051004-A/22257: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct
LF829461
JP 2016528161-A/22294: COMBINATION THERAPY FOR TREATING HEARING AND BALANCE DISORDERS.
18
RNA
synthetic construct
DL612907
JP 2011092200-A/22305: NEISSERIAL ANTIGENIC PEPTIDES.
8
PRT
Neisseria
MC774415
JP 2018525446-A/22305: COMPOUNDS FOR INDUCING TISSUE FORMATION AND USES THEREOF.
38
PRT
synthetic construct
LF681526
JP 2016521556-A/22305: COMPOSITIONS AND METHODS FOR MODULATING FOXP3 EXPRESSION.
15
DNA
Homo sapiens
HW187333
JP 2013102767-A/22257: Novel siRNA's and Use Thereof.
21
RNA
synthetic construct